Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC

Int J Hematol. 2009 Dec;90(5):571-575. doi: 10.1007/s12185-009-0433-z. Epub 2009 Oct 29.

Abstract

Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by a defect of phagocyte NADPH-oxidase and characterized by severe, recurrent bacterial and fungal infections. Invasive aspergillosis (IA) is the leading cause of mortality in patients with CGD. We report the case of a 3-year-old boy with CGD, who developed IA despite antifungal prophylaxis. His treatment consisted of a 10-month-long multi-drug antifungal therapy, together with surgery, but these did not cause any substantial clinical improvement. BMT in high-risk patients with CGD remains a challenge due to both, higher risk of graft rejection and inflammatory flare in the course of immune recovery. Our patient rejected the first matched unrelated donor (MUD) allograft after RIC regimen recommended by the EBMT Inborn Errors Working Party for high-risk patients. After treosulfan-based conditioning and second MUD peripheral blood stem cell transplantation both, full reconstitution of the granulocytic series and complete recovery from IA, were achieved.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use
  • Aspergillosis / therapy*
  • Busulfan / analogs & derivatives*
  • Busulfan / therapeutic use
  • Child, Preschool
  • Graft Survival
  • Granulomatous Disease, Chronic / complications
  • Granulomatous Disease, Chronic / therapy*
  • Humans
  • Male
  • Peripheral Blood Stem Cell Transplantation / methods*
  • Reoperation / methods*
  • Transplantation Conditioning / methods*

Substances

  • Antineoplastic Agents, Alkylating
  • treosulfan
  • Busulfan